ARS Pharmaceuticals, Inc. (SPRY) Return On Equity

Annual ROE:

3.28%+24.87%(+115.19%)
December 31, 2024

Summary

  • As of today, SPRY annual return on equity is 3.28%, with the most recent change of +24.87% (+115.19%) on December 31, 2024.
  • During the last 3 years, SPRY annual ROE has risen by +12.75% (+134.64%).
  • SPRY annual ROE is now at all-time high.

Performance

SPRY ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSPRYprofitability metrics

Quarterly ROE:

-38.98%-17.04%(-77.67%)
September 30, 2025

Summary

  • As of today, SPRY quarterly return on equity is -38.98%, with the most recent change of -17.04% (-77.67%) on September 30, 2025.
  • Over the past year, SPRY quarterly ROE has dropped by -16.82% (-75.90%).
  • SPRY quarterly ROE is now -111.67% below its all-time high of 334.04%, reached on June 1, 2020.

Performance

SPRY Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSPRYprofitability metrics

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

SPRY ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+115.2%-75.9%
3Y3 Years+134.6%-164.8%
5Y5 Years+100.9%-500.6%

SPRY ROE Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+115.0%-1198.0%at low
5Y5-Yearat high+100.9%-111.7%at low
All-TimeAll-Timeat high+100.9%-111.7%at low

SPRY ROE History

DateAnnualQuarterly
Sep 2025
-
-38.98%(-77.7%)
Jun 2025
-
-21.94%(-215.7%)
Mar 2025
-
-6.95%(-295.8%)
Dec 2024
3.28%(+115.2%)
3.55%(+116.0%)
Sep 2024
-
-22.16%(-14.2%)
Jun 2024
-
-19.40%(+6.2%)
Mar 2024
-
-20.68%(+7.0%)
Dec 2023
-21.59%(+1.1%)
-22.24%(-4.9%)
Sep 2023
-
-21.21%(-23.5%)
Jun 2023
-
-17.18%(-34.2%)
Mar 2023
-
-12.80%(+13.0%)
Dec 2022
-21.84%
-
DateAnnualQuarterly
Sep 2022
-
-14.72%(+22.8%)
Jun 2022
-
-19.07%(+18.8%)
Mar 2022
-
-23.49%(+8.3%)
Dec 2021
-9.47%(+45.8%)
-
Dec 2021
-
-25.61%(-16.0%)
Sep 2021
-
-22.08%(-28.8%)
Jun 2021
-
-17.14%(-67.5%)
Mar 2021
-
-10.23%(-57.6%)
Dec 2020
-17.47%(+95.4%)
-6.49%(-101.9%)
Jun 2020
-
334.04%(+52.8%)
Mar 2020
-
218.62%(+75.7%)
Dec 2019
-380.61%(-294.0%)
124.40%
Dec 2018
-96.60%
-

FAQ

  • What is ARS Pharmaceuticals, Inc. annual return on equity?
  • What is the all-time high annual ROE for ARS Pharmaceuticals, Inc.?
  • What is ARS Pharmaceuticals, Inc. annual ROE year-on-year change?
  • What is ARS Pharmaceuticals, Inc. quarterly return on equity?
  • What is the all-time high quarterly ROE for ARS Pharmaceuticals, Inc.?
  • What is ARS Pharmaceuticals, Inc. quarterly ROE year-on-year change?

What is ARS Pharmaceuticals, Inc. annual return on equity?

The current annual ROE of SPRY is 3.28%

What is the all-time high annual ROE for ARS Pharmaceuticals, Inc.?

ARS Pharmaceuticals, Inc. all-time high annual return on equity is 3.28%

What is ARS Pharmaceuticals, Inc. annual ROE year-on-year change?

Over the past year, SPRY annual return on equity has changed by +24.87% (+115.19%)

What is ARS Pharmaceuticals, Inc. quarterly return on equity?

The current quarterly ROE of SPRY is -38.98%

What is the all-time high quarterly ROE for ARS Pharmaceuticals, Inc.?

ARS Pharmaceuticals, Inc. all-time high quarterly return on equity is 334.04%

What is ARS Pharmaceuticals, Inc. quarterly ROE year-on-year change?

Over the past year, SPRY quarterly return on equity has changed by -16.82% (-75.90%)
On this page